These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 14506038)
1. Pentamidine is active in vitro against Fusarium species. Lionakis MS; Lewis RE; Samonis G; Kontoyiannis DP Antimicrob Agents Chemother; 2003 Oct; 47(10):3252-9. PubMed ID: 14506038 [TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Lewis RE; Wiederhold NP; Klepser ME Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887 [TBL] [Abstract][Full Text] [Related]
3. [Detection of virulence factors and antifungal susceptibilities of Fusarium strains isolated from keratitis cases]. Çuhadar T; Karabıçak N; Özdil T; Özgür D; Otağ F; Hızel K; Kalkancı A Mikrobiyol Bul; 2018 Jul; 52(3):247-258. PubMed ID: 30156511 [TBL] [Abstract][Full Text] [Related]
4. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. Arikan S; Lozano-Chiu M; Paetznick V; Nangia S; Rex JH J Clin Microbiol; 1999 Dec; 37(12):3946-51. PubMed ID: 10565912 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the inhibitory effect of amphotericin B on the apical growth of F. solani using the BioCell-Tracer system. Teixeira AB; Moretti ML; Machado HC; Nishimura K; Taguchi H; Schreiber AZ Mycoses; 2007 May; 50(3):183-8. PubMed ID: 17472613 [TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of (KW)n or (RW)n peptide against Fusarium solani and Fusarium oxysporum. Gopal R; Na H; Seo CH; Park Y Int J Mol Sci; 2012 Nov; 13(11):15042-53. PubMed ID: 23203110 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes. Badali H; Cañete-Gibas C; Patterson H; Sanders C; Mermella B; Garcia V; Mele J; Fan H; Wiederhold NP Mycoses; 2021 Jul; 64(7):748-752. PubMed ID: 33755988 [TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Reuben A; Anaissie E; Nelson PE; Hashem R; Legrand C; Ho DH; Bodey GP Antimicrob Agents Chemother; 1989 Sep; 33(9):1647-9. PubMed ID: 2817867 [TBL] [Abstract][Full Text] [Related]
9. In vitro sensitivity of medically significant Fusarium species to various antimycotics. Sekhon AS; Padhye AA; Garg AK; Ahmad H; Moledina N Chemotherapy; 1994; 40(4):239-44. PubMed ID: 8082411 [TBL] [Abstract][Full Text] [Related]
10. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method. Espinel-Ingroff A; Colombo AL; Cordoba S; Dufresne PJ; Fuller J; Ghannoum M; Gonzalez GM; Guarro J; Kidd SE; Meis JF; Melhem TM; Pelaez T; Pfaller MA; Szeszs MW; Takahaschi JP; Tortorano AM; Wiederhold NP; Turnidge J Antimicrob Agents Chemother; 2016 Feb; 60(2):1079-84. PubMed ID: 26643334 [TBL] [Abstract][Full Text] [Related]
11. Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes. Oechsler RA; Feilmeier MR; Miller D; Shi W; Hofling-Lima AL; Alfonso EC Cornea; 2013 May; 32(5):667-73. PubMed ID: 23343947 [TBL] [Abstract][Full Text] [Related]
12. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex. Homa M; Shobana CS; Singh YR; Manikandan P; Selvam KP; Kredics L; Narendran V; Vágvölgyi C; Galgóczy L Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826 [TBL] [Abstract][Full Text] [Related]
13. Effect of the Novel Antifungal Drug F901318 (Olorofim) on Growth and Viability of Aspergillus fumigatus. du Pré S; Beckmann N; Almeida MC; Sibley GEM; Law D; Brand AC; Birch M; Read ND; Oliver JD Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891595 [TBL] [Abstract][Full Text] [Related]
14. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Tortorano AM; Prigitano A; Esposto MC; Arsic Arsenijevic V; Kolarovic J; Ivanovic D; Paripovic L; Klingspor L; Nordøy I; Hamal P; Arikan Akdagli S; Ossi C; Grancini A; Cavanna C; Lo Cascio G; Scarparo C; Candoni A; Caira M; Drogari Apiranthitou M; Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1623-30. PubMed ID: 24791951 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antifungal efficacy of plant based lawsone against Fusarium oxysporum species complex. Dananjaya SHS; Udayangani RMC; Shin SY; Edussuriya M; Nikapitiya C; Lee J; De Zoysa M Microbiol Res; 2017 Aug; 201():21-29. PubMed ID: 28602398 [TBL] [Abstract][Full Text] [Related]
16. Biofilm characterization of Fusarium solani keratitis isolate: increased resistance to antifungals and UV light. Córdova-Alcántara IM; Venegas-Cortés DL; Martínez-Rivera MÁ; Pérez NO; Rodriguez-Tovar AV J Microbiol; 2019 Jun; 57(6):485-497. PubMed ID: 31134579 [TBL] [Abstract][Full Text] [Related]
17. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Tortorano AM; Prigitano A; Dho G; Esposto MC; Gianni C; Grancini A; Ossi C; Viviani MA Antimicrob Agents Chemother; 2008 Jul; 52(7):2683-5. PubMed ID: 18443107 [TBL] [Abstract][Full Text] [Related]
18. Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India. Tupaki-Sreepurna A; Thanneru V; Natarajan S; Sharma S; Gopi A; Sundaram M; Kindo AJ Mycopathologia; 2018 Jun; 183(3):529-540. PubMed ID: 29445920 [TBL] [Abstract][Full Text] [Related]